Ligand Reports First Quarter 2021 Financial Results
Go back to Ligand Reports First Quarter 2021 Financial Results| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 290.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $290.07 | 52 Week High | $139.79 | |||
| Open | $290.07 | 52 Week Low | $82.07 | |||
| Day High | $290.07 | P/E | 674.58 | |||
| Day Low | $290.07 | EPS | $0.43 | |||
| Volume | 716 | |||||

